News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Verratti Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 3,360 shares
@ $15.01, valued at
$50.4k
Paid exercise price by delivering 5,006 shares
@ $15.01, valued at
$75.1k
|
|
| 09/27/2023 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 3,523 shares
@ $15.99, valued at
$56.3k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 1,083 shares
@ $23.72, valued at
$25.7k
Paid exercise price by delivering 1,586 shares
@ $23.72, valued at
$37.6k
|
|
| 03/23/2023 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 1,351 shares
@ $22.91, valued at
$31k
|
|
| 03/16/2023 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 39,405 shares
@ $0 |
|
| 10/11/2022 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 3,360 shares
@ $19.62, valued at
$65.9k
Paid exercise price by delivering 5,006 shares
@ $19.62, valued at
$98.2k
|
|
| 09/27/2022 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 2,793 shares
@ $18.69, valued at
$52.2k
Paid exercise price by delivering 2,293 shares
@ $18.41, valued at
$42.2k
|
|
| 09/22/2022 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 702 shares
@ $20.2, valued at
$14.2k
|
|
| 08/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2022 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 03/25/2022 |
4
| Verratti Mark (President, Mental Health) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 1,082 shares
@ $25.32, valued at
$27.4k
Paid exercise price by delivering 1,584 shares
@ $25.32, valued at
$40.1k
|
|
| 03/23/2022 |
4
| Verratti Mark (President, Mental Health) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 19,238 shares
@ $0 |
|
| 02/18/2022 |
4
| Verratti Mark (President, Mental Health) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 22,616 shares
@ $0 |
|
| 10/12/2021 |
4
| Verratti Mark (President, Myriad Neuroscience) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Paid exercise price by delivering 3,349 shares
@ $30.88, valued at
$103.4k
Paid exercise price by delivering 4,991 shares
@ $30.88, valued at
$154.1k
|
|
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 31,258 shares
@ $0 |
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 7,467 shares
@ $0 |
|
| 10/01/2019 |
4
| Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Disposed/sold 725 shares
@ $28.63, valued at
$20.8k
|
|
| 09/26/2019 |
4
| Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Disposed/sold 2,897 shares
@ $29.93, valued at
$86.7k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2018 |
4
| Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2013 |
4
| Verratti Mark (VP Global Sales) has filed a Form 4 on CYBERONICS INC|
Txns:
| Sold 18,750 shares
@ $71.1188, valued at
$1.3M
Exercised 18,750 options to buy
@ $37.9, valued at
$710.6k
|
|
| 12/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2013 |
4
| Verratti Mark (VP Global Sales) has filed a Form 4 on CYBERONICS INC|
Txns:
| Paid exercise price by delivering 777 shares
@ $0 |
|
|
|
|